Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma.

ABSTRACT:

SUBMITTER: Zheng G 

PROVIDER: S-EPMC12624805 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature